Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 07/10/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 07/09/22
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study | NCT05440357 | Xinhua Zhang, MD | user2@example.com | None | 2022-07-01 | 2025-09-30 | 2026-09-30 | - | - | 2025-07-14 |
| Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA | NCT05461664 | Xinhua Zhang, MD | user2@example.com | None | 2022-07-10 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors | NCT05464875 | Xinhua Zhang, MD | user2@example.com | None | 2022-07-09 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |